Screener
GeneDx Holdings WGS Other — Adjusted cost of services
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept wgs:AdjustedCostOfGoodSold.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
| Line item | Three months ended March 31, 2026 / Gene Dx | Three months ended March 31, 2026 / Other | Three months ended March 31, 2026 / Total | Three months ended March 31, 2025 / Gene Dx | Three months ended March 31, 2025 / Other | Three months ended March 31, 2025 / Total |
|---|---|---|---|---|---|---|
| Revenue | $101,496 | $758 | $102,254 | $87,115 | — | $87,115 |
| Adjusted cost of services | 31,613 | 588 | 32,201 | 27,396 | — | 27,396 |
| Adjusted gross profit(1) | 69,883 | 170 | 70,053 | 59,719 | — | 59,719 |
| Reconciliations: | ||||||
| Depreciation and amortization | 1,462 | 1,075 | ||||
| Stock-based compensation | 380 | 168 | ||||
| Gross profit | $68,211 | $58,476 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is GeneDx Holdings's other — adjusted cost of services?
- GeneDx Holdings (WGS) reported other — adjusted cost of services of $588K in Q1 2026.
- What does other — adjusted cost of services mean?
- This metric captures the direct costs associated with providing services within the Other business segment, adjusted to exclude non-recurring or non-cash items. It represents the variable expenses incurred to generate revenue for these specific secondary operations. Analyzing this cost structure is essential for evaluating the operational efficiency and direct expense management of non-core business units.
Ask your AI about GeneDx Holdings's other — adjusted cost of services.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude